Predicting coronary heart disease in renal transplant recipients: A prospective study
Authors:
- Didier DuclouxDDDidier Ducloux
- Amir KazoryAKAmir Kazory
- Jean-Marc ChalopinJCJean-Marc Chalopin
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 66 (1) , 441-447
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cardiovascular Risk Factors and Estimated Risk for CAD in a Randomized Trial Comparing Calcineurin Inhibitors in Renal TransplantationAmerican Journal of Transplantation, 2003
- Improved Cardiovascular Risk Profile and Renal Function in Renal Transplant Patients after Randomized Conversion from Cyclosporine to TacrolimusJournal of the American Society of Nephrology, 2003
- Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trialThe Lancet, 2003
- Effects of Sirolimus on Lipids in Renal Allograft Recipients: An Analysis Using the Framingham Risk ModelAmerican Journal of Transplantation, 2002
- Guidelines on preventing cardiovascular disease in clinical practiceBMJ, 2000
- Effect of Statins on Risk of Coronary DiseaseJAMA, 1999
- Enhanced Reduction of Fasting Total Homocysteine Levels With Supraphysiological Versus Standard Multivitamin Dose Folic Acid Supplementation in Renal Transplant RecipientsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Hypertension in the ElderlyJAMA, 1994